EP Patent

EP4175964A1 — Conjugated oligonucleotide compounds, methods of making and uses thereof

Assigned to Tangram Therapeutics Plc · Expires 2023-05-10 · 3y expired

What this patent protects

The present invention provides novel conjugated oligonucleotide compounds, which are suitable for therapeutic use. Additionally, the present invention provides methods of making these compounds, as well as methods of using such compounds for the treatment of various diseases and …

USPTO Abstract

The present invention provides novel conjugated oligonucleotide compounds, which are suitable for therapeutic use. Additionally, the present invention provides methods of making these compounds, as well as methods of using such compounds for the treatment of various diseases and conditions.

Drugs covered by this patent

Patent Metadata

Patent number
EP4175964A1
Jurisdiction
EP
Classification
—
Expires
2023-05-10
Drug substance claim
No
Drug product claim
No
Assignee
Tangram Therapeutics Plc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.